Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11958845 Heterocyclic compound

Patent 11958845 was granted and assigned to Takeda Pharmaceutical Company on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Takeda Pharmaceutical Company

0

Current Assignee

Takeda Pharmaceutical Company

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Junsi Wang0

Masato Yoshikawa0

Takahito Kasahara0

Jinxing Li0

Hideyuki Sugiyama0

Masahiro Ito0

Takeshi Yamamoto0

Keiko Kakegawa0

Date of Patent

April 16, 2024

0

Patent Application Number

179525460

Date Filed

September 26, 2022

0

Patent Citations

US Patent 8067472 Methods of treating Hodgkin's and non-Hodgkin's lymphoma

0

US Patent 7250504 Class II human histone deacetylases, and uses related thereto

0

US Patent 7879865 Treatment of cancer of the brain using histone deacetylase inhibitors

0

US Patent 8026260 Histone deacetylase inhibitors with aryl-pyrazolyl-motifs

0

US Patent 9056843 Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease

0

US Patent 9096559 4-carboxybenzylamino derivatives as histone deacetylase inhibitors

0

US Patent 9238028 HDAC inhibitors to treat charcot-marie-tooth disease

0

US Patent 9365498 Inhibitors of histone deacetylase

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11958845 Heterocyclic compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool